| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2023 | ENOV Enovis Corp | Lang Patricia A70 | SVP, Chief Hr Officer | Sell | 1,963 | $56.09 | $110,104.67 | -10.7% | -7.4% | +7.4% | |
| Feb 27, 2023 | ATEC Alphatec Holdings, Inc. | Koning John Todd57 | Chief Financial Officer | Sell | 22,500 | $14.76 | $332,100.00 | -4.9% | -0.1% | +3.3% | |
| Feb 27, 2023 | TMDX Transmedics Group, Inc. | Weill David63 | Director | Sell | 5,934 | $76.69 | $455,099.66 | -19.2% | -7.2% | +13.8% | |
| Feb 27, 2023 | LMAT Lemaitre Vascular Inc | Ross Bridget A | Director | Sell | 7,000 | $49.27 | $344,890.00 | -85.5% | +26.1% | +26.4% | |
| Feb 27, 2023 | AORT Artivion, Inc. | MacKin James P53 | President &CEO | Sell | 22,630 | $12.94 | $292,786.94 | -2.1% | +14.7% | +51.1% | |
| Feb 27, 2023 | AORT Artivion, Inc. | Getz Matthew A | VP, Human Resources | Sell | 1,600 | $12.94 | $20,700.80 | -2.3% | +14.7% | +51.1% | |
| Feb 27, 2023 | AORT Artivion, Inc. | Green Andrew M | VP Regulatory | Sell | 1,747 | $12.94 | $22,602.69 | -3.8% | +14.7% | +51.1% | |
| Feb 27, 2023 | AORT Artivion, Inc. | Maier Dennis B50 | SVP, Operations | Sell | 2,330 | $12.94 | $30,145.54 | -2.5% | +14.7% | +51.1% | |
| Feb 27, 2023 | AORT Artivion, Inc. | Lee David Ashley46 | Executive VP, COO &CFO | Sell | 3,094 | $12.94 | $40,030.17 | -0.5% | +14.7% | +51.1% | |
| Feb 27, 2023 | AORT Artivion, Inc. | Stanton Marshall S.51 | SVP, Clinical &MD Affair | Sell | 2,337 | $12.94 | $30,236.11 | -2.5% | +14.7% | +51.1% | |
| Feb 27, 2023 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 1,960 | $12.94 | $25,358.48 | -0.8% | +14.7% | +51.1% | |
| Feb 27, 2023 | AORT Artivion, Inc. | Horton Amy48 | VP, Chief Accounting Officer | Sell | 1,419 | $12.94 | $18,359.02 | -0.7% | +14.7% | +51.1% | |
| Feb 27, 2023 | AORT Artivion, Inc. | Davis John E | Senior VP, Global Sales | Sell | 2,393 | $12.94 | $30,960.63 | -1.0% | +14.7% | +51.1% | |
| Feb 24, 2023 | CTKB Cytek Biosciences, Inc. | Jeanmonod Patrik77 | Chief Financial Officer | Sell | 3,000 | $11.05 | $33,150.00 | -2.6% | -29.1% | -21.9% | |
| Feb 24, 2023 | PETV Petvivo Holdings, Inc. | Jasper Joseph William | Director | Buy | 2,600 | $2.98 | $7,736.00 | +7.0% | - | - | |
| Feb 24, 2023 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 2,500 | $2.81 | $7,022.75 | -0.8% | -21.4% | -87.5% | |
| Feb 23, 2023 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Buy | 37,500 | $2.86 | $107,141.25 | +14.9% | -21.5% | -87.9% | |
| Feb 23, 2023 | AVTR Avantor, Inc. | Couturier Christophe75 | EVP, Amea | Sell | 3,078 | $24.24 | $74,610.72 | -3.2% | -17.0% | -1.0% | |
| Feb 23, 2023 | TMDX Transmedics Group, Inc. | Tobin James R60 | Director | Sell | 10,000 | $75.13 | $751,300.00 | -3.9% | -8.0% | +6.9% | |
| Feb 23, 2023 | DXCM Dexcom Inc | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 412 | $111.64 | $45,995.68 | -0.3% | +4.3% | +3.9% | |
| Feb 23, 2023 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 37,827 | $73.65 | $2,786,084.71 | -1.8% | -8.0% | +6.9% | |
| Feb 23, 2023 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 35,930 | $73.51 | $2,641,113.62 | -14.8% | -8.0% | +6.9% | |
| Feb 23, 2023 | ENOV Enovis Corp | Shirley Brady60 | Pres. &COO | Sell | 2,722 | $58.72 | $159,848.06 | -2.8% | -6.6% | +9.1% | |
| Feb 23, 2023 | ENOV Enovis Corp | Lang Patricia A70 | SVP, Chief Hr Officer | Sell | 985 | $58.76 | $57,878.35 | -3.3% | -6.6% | +9.1% | |
| Feb 23, 2023 | ATEC Alphatec Holdings, Inc. | Lish Scott61 | SVP, Development | Sell | 22,070 | $14.22 | $313,796.40 | -2.3% | +2.9% | +4.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.